A study in the APP/PS1 mutant mouse model of Alzheimer’s disease, which expresses the transgenes for both mutant APP and mutant presenilin-1 (PS1), demonstrated that transgenic mice develop significant cognitive impairments in spatial working memory and accumulation of amyloid beta in brain tissue [132]. This evidence concerns the gene APP and Alzheimer disease.